Related Experiment Video
Updated: Aug 10, 2026

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
Published on: August 12, 2019
Blocking of monocyte chemoattractant protein-1 during tubulointerstitial nephritis resulted in delayed neutrophil
Ping Li1, Gabriela E Garcia, Yiyang Xia
1Department of Medicine, Renal and Infectious Disease Sections, Baylor College of Medicine, Houston, TX 77030. lfeng@bcm.tmc.edu
Insights
Monocyte chemoattractant protein-1 (MCP-1) drives kidney inflammation in tubulointerstitial nephritis (TIN). Blocking MCP-1 with antibodies or antagonists reduced macrophage infiltration but delayed neutrophil clearance in TIN rat models.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Monocyte chemoattractant protein (MCP)-1 is linked to monocyte/macrophage infiltration in tubulointerstitial nephritis (TIN).
- Understanding MCP-1's role is crucial for developing targeted therapies for TIN.
Purpose of the Study:
- To investigate the specific role of MCP-1 in the pathogenesis of TIN in a rat model.
- To evaluate the therapeutic potential of neutralizing MCP-1 activity in TIN.
Main Methods:
- Administration of a neutralizing anti-MCP-1 antibody (Ab) and a peptide-based MCP-1 receptor antagonist (RA) in TIN rat models.
- Assessment of macrophage infiltration and neutrophil clearance in kidney tissues.
- In vitro assays to examine MCP-1's effect on macrophage-mediated phagocytosis.
- Immunoprecipitation and pull-down assays to confirm antibody-antigen binding.
Main Results:
- Treatment with anti-MCP-1 Ab significantly reduced macrophage infiltration in TIN rat kidneys.
- Neutrophil clearance was delayed in TIN model rats treated with either anti-MCP-1 Ab or MCP-1 RA.
- MCP-1 did not directly impair macrophage phagocytosis of neutrophils in vitro.
- The anti-MCP-1 Ab formed immune complexes with heparan sulfate-immobilized MCP-1 in the kidneys.
Conclusions:
- MCP-1 induction correlates with leukocyte infiltration in TIN.
- MCP-1 antagonism, via antibody or receptor antagonist, alters TIN pathology, potentially by delaying apoptotic neutrophil removal.
- Targeting MCP-1 presents a potential therapeutic strategy for managing TIN.
Abstract:
The chemokine monocyte chemoattractant protein (MCP)-1 has been implicated in the monocyte/macrophage infiltration that occurs during tubulointerstitial nephritis (TIN). We investigated the role of MCP-1 in rats with TIN by administering a neutralizing anti-MCP-1 antibody (Ab). We observed significantly reduced macrophage infiltration and delayed neutrophil clearance in the kidneys of TIN model rats treated with the anti-MCP-1 Ab. To exclude the possibility that an observed immune complex could affect the resolution of apoptotic neutrophils via the Fc receptor, TIN model rats were treated with a peptide-based MCP-1 receptor antagonist (RA). The MCP-1 RA had effects similar to those of the anti-MCP-1 Ab. In addition, MCP-1 did not affect macrophage-mediated phagocytosis of neutrophils in vitro. Deposition of the anti-MCP-1 Ab in rat kidneys resulted from its binding to heparan sulfate-immobilized MCP-1, as demonstrated by the detection of MCP-1 in both pull-down and immunoprecipitation assays. We conclude that induction of chemokines, specifically MCP-1, in TIN corresponds with leukocyte infiltration and that the anti-MCP-1 Ab formed an immune complex with heparan sulfate-immobilized MCP-1 in the kidney. Antagonism of MCP-1 in TIN by Ab or RA may alter the pathological process, most likely through delayed removal of apoptotic neutrophils in the inflammatory loci.
More Related Videos
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024